Microfluidic Biotherapeutic Production With On-Chip Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing biotherapeutic manufacturing processes are large-scale, costly, and not suitable for point-of-care applications due to low protein yield and lack of miniaturization and automation, necessitating a need for flexible, scalable, and portable systems for on-demand production.
Innovation Solution
A fully integrated microfluidic system, or 'factory-on-a-chip', comprising a bioreactor unit, mixer/debubbler, and purification unit with chromatography columns, capable of producing single-dose biotherapeutics on-demand using a cell-free reaction system, integrated with sensors for real-time monitoring and quality control.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If large-scale fermentation batches are used for biotherapeutic production, then production capacity is improved, but device complexity and cost increase significantly
Solution Approach 1:
The patent divides the large-scale biotherapeutic production process into multiple micro-scale units, each capable of independent operation. The microfluidic system segments the fermentation, purification, and formulation processes into separate micro-channels and modules, allowing parallel processing and significantly reducing the complexity of each individual component while maintaining overall production capacity.
Solution Approach 2:
The patent replaces traditional large-scale mechanical mixing and processing systems with automated microfluidic systems that use precise computer-controlled pumping and mixing. This substitution of mechanical systems with automated microfluidic control reduces operational complexity and enables better process monitoring and control.
2Loss of time
If cell-free extracts are used for protein production, then production time is reduced, but protein yield decreases
Solution Approach 1:
The patent combines multiple cell-free extract systems in parallel within the microfluidic platform, merging their protein production capabilities. By integrating multiple reaction channels that simultaneously produce protein, the system achieves both rapid production (inherent advantage of cell-free extracts) and sufficient total yield through parallel processing of multiple extracts.
Solution Approach 2:
The patent implements continuous-flow production through the microfluidic system, where cell-free extracts continuously generate protein as feedstock flows through the micro-channels. This continuous operation maintains high production speed while the accumulated protein from continuous flow compensates for the lower yield per unit volume of individual extracts.
3Volume of moving object
If miniaturization is implemented for point-of-care applications, then portability is improved, but purification capability deteriorates
Solution Approach 1:
The patent extracts and isolates the essential purification functions into specialized micro-modules that can be independently integrated. By separating the purification step into dedicated micro-channels with specific stationary phases, the system maintains effective purification capability even at miniaturized scales, removing the limitation that miniaturization inherently compromises purification performance.
Solution Approach 2:
The patent utilizes porous stationary phases and porous materials within the microfluidic channels to enable effective protein purification at the micro-scale. The porous structure provides large surface area for interaction while maintaining small channel dimensions, allowing the system to achieve both miniaturization and effective purification simultaneously.
4Measurement precision
If real-time monitoring sensors are integrated, then quality control is improved, but device complexity increases
Solution Approach 1:
The patent merges multiple sensing functions into integrated micro-modules that are built directly into the microfluidic platform. By combining pH sensing, optical detection, and other monitoring capabilities into unified sensor units that share the same micro-channel infrastructure, the system achieves comprehensive real-time monitoring without proportionally increasing overall device complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables on-demand production and delivery of biotherapeutics within one hour to one day, maintaining protein potency and viability, suitable for point-of-care settings such as ambulances, patient bedsides, and resource-limited areas.
Implementation Method 1
capable of continuous-flow production of biotherapeutics at the microscale using a cell-free reaction system
Implementation Method 2
a microfluidic purification unit communicatively connected to the microfluidic mixer/de-bubbler unit comprising at least one purification column for capturing the crude protein and providing a purified protein
Implementation Method 3
sensors for monitoring pH, ionic strength, UV-Vis absorbance, fluorescence, light scatter and or circular dichroism for testing of the purified protein
Implementation Method 4
sensors for monitoring pH, ionic strength, UV-Vis absorbance, fluorescence, light scatter and or circular dichroism for testing of the purified protein
Data Source
AI summary
The present invention provides for a fully integrated microfluidic system capable of producing single-dose amounts of biotherapeutics at the point-of-care wherein protein production, purification and product harvest are all integrated as a single microfluidic device which is portable and capable of continuous-flow production of biotherapeutics at the microscale using a cell-free reaction system.